2011 No. 153
The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2011
Made
Coming into operation
The Department of Health, Social Services and Public Safety makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 19711 as adapted by section 38 of that Act and now vested in it2.
In accordance with section 31(3) of that Act, it has consulted with the Advisory Council on the Misuse of Drugs.
Citation and commencementI11
These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2011 and shall come into operation on 28th March 2011.
InterpretationI22
1
In these Regulations, “the 2002 Regulations” means the Misuse of Drugs Regulations (Northern Ireland) 20023.
2
The Interpretation Act (Northern Ireland) 19544 shall apply to these Regulations as it applies to an Act of the Assembly.
Amendment of the 2002 Regulations
I33
The 2002 Regulations shall be amended as follows.
I44
For regulation 4B, substitute
4BExceptions for gamma–butyrolactone and 1, 4–butanediol
1
Gamma–butyrolactone and 1,4–butanediol are excepted from sections 3(1) (import and export), 4(1) (production and supply) and 5(1) (possession) of the Act save where a person imports, exports, produces, supplies or offers to supply either substance, or has either substance in his possession, knowing or believing that it will be used for the purpose of human ingestion whether by himself or another person other than as a flavouring in food.
2
In this regulation references to gamma–butyrolactone include—
a
any salt of gamma–butyrolactone; and
b
any preparation or other product containing gamma–butyrolactone or a substance specified in sub–paragraph (a) of this paragraph.
3
In this regulation references to 1, 4-butanediol include—
a
any substance which is an ester or ether or both an ester and ether of 1,4‑butanediol;
b
any salt of 1, 4–butanediol or of a substance specified in sub–paragraph (a) of this paragraph; and
c
any preparation or other product containing 1, 4–butanediol or a substance specified in sub–paragraph (a) or (b) of this paragraph.
I55
In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27) omit “4‑Methylmethcathinone”.
I66
In paragraph 1 of Schedule 2 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 21, 23, 26 and 27)—
a
after “Alphaprodine”, insert “Amineptine”; and
b
after “Sufentanil”, insert “Tapentadol”.
Revocations
I77
Regulation 3 of the Misuse of Drugs (Amendment No.2) Regulations (Northern Ireland) 20095 is revoked.
I88
Paragraph (a) of regulation 4 of the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 20106 is revoked.
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 23rd March 2011
(This note is not part of the Regulations)